Details
Stereochemistry | ACHIRAL |
Molecular Formula | C11H8O2 |
Molecular Weight | 172.18 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=CC(=O)C2=C(C=CC=C2)C1=O
InChI
InChIKey=MJVAVZPDRWSRRC-UHFFFAOYSA-N
InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3
Molecular Formula | C11H8O2 |
Molecular Weight | 172.18 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f159f62-0c66-4292-9255-e6747db6208d | http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/UCM264117
Curator's Comment: description was created based on several sources, including:
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f159f62-0c66-4292-9255-e6747db6208d | http://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/UCM264117
Menadione, a drug belong to class of Vitamin K, is prescribed for the treatment of hemorrhage, vitamin K deficiency, moderate to severe forms of hypoprothrombinaemia in adults and children. Menadione is a synthetic form of vitamin K, a lipid-soluble vitamin. Vitamin K is a vital cofactor for the biosynthesis of prothrombin, factor VII, IX, X, protein C and protein S. Menadione supports the functions of osteocalcin. Large doses of menadione have been reported to cause adverse outcomes including hemolytic anemia due to glucose-6-phosphate dehydrogenase deficiency, neonatal brain or liver damage, or neonatal death in some rare cases.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: WP558 |
|||
Target ID: map04977 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | MENADIONE Approved UseThe additive is used or intended for use as a nutritional supplement for the Prevention of vitamin K deficiency as follows:
(1) In chicken and turkey feed at a level not to exceed 2 grams per ton of complete feed.
(2) In the feed of growing and finishing swine at a level not to exceed 10 grams per ton of feed. Launch Date1962 |
|||
Primary | MENADIONE Approved UseMenadione Indications: severe hypoprothrombinaemia Launch Date1962 |
|||
Palliative | MENADIONE Approved UseINDICATIONS: For temporary relief of joint pains, bruising, fatigue, abdominal discomfort, diarrhea, and hay fever. |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
Drug as perpetrator​
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
likely | ||||
yes [IC50 2.36 uM] | ||||
yes [IC50 4.39 uM] | ||||
yes [IC50 4.51 uM] | ||||
yes [IC50 4.6 uM] | ||||
yes [IC50 5.58 uM] | ||||
yes [IC50 5.76 uM] | ||||
yes [IC50 5.92 uM] | ||||
yes [IC50 7.02 uM] | ||||
yes [IC50 8.01 uM] | ||||
yes [IC50 8.24 uM] | ||||
yes [IC50 8.51 uM] | ||||
yes [IC50 8.91 uM] | ||||
yes [IC50 9.77 uM] | ||||
Sources: https://pubmed.ncbi.nlm.nih.gov/15603920/ |
yes | |||
Sources: https://pubmed.ncbi.nlm.nih.gov/15603920/ |
yes |
Drug as victim
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Gene discovery within the planctomycete division of the domain Bacteria using sequence tags from genomic DNA libraries. | 2002 |
|
Lateral gene transfer and parallel evolution in the history of glutathione biosynthesis genes. | 2002 |
|
Synthesis, electrochemical and spectral properties of some omega-N-quinonyl amino acids. | 2002 |
|
Effect of dicumarol, a Nad(P)h: quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes. | 2002 Apr |
|
Difference in the metabolism of vitamin K between liver and bone in vitamin K-deficient rats. | 2002 Apr |
|
Oxidant stress induces gamma-glutamylcysteine synthetase and glutathione synthesis in human bronchial epithelial NCI-H292 cells. | 2002 Apr |
|
Roles of NapF, NapG and NapH, subunits of the Escherichia coli periplasmic nitrate reductase, in ubiquinol oxidation. | 2002 Apr |
|
Reconstitution of coupled fumarate respiration in liposomes by incorporating the electron transport enzymes isolated from Wolinella succinogenes. | 2002 Apr |
|
Purification and characterization of the complex I from the respiratory chain of Rhodothermus marinus. | 2002 Dec |
|
Analysis of the differences in microbial community structures between suspended and sessile microorganisms in rivers based on quinone profile. | 2002 Feb |
|
Differential lipoprotein transport pathways of K-vitamins in healthy subjects. | 2002 Feb 15 |
|
Salt effects on the reactions of radical ion pairs formed by electron transfer quenching of triplet 2-methyl-1,4-naphthoquinone by amines. Optical flash photolysis and step-scan FTIR investigations. | 2002 Jan |
|
Gordonia westfalica sp. nov., a novel rubber-degrading actinomycete. | 2002 Jul |
|
Isolation and characterization of a Gram-positive polyphosphate-accumulating bacterium. | 2002 Jun |
|
Role of antioxidant defences in the species-specific response of isolated atria to menadione. | 2002 Jun |
|
The expression of gamma-glutamyltransferase in rat colon carcinoma cells is distinctly regulated during differentiation and oxidative stress. | 2002 Mar |
|
Saccharomonospora halophila sp. nov., a novel halophilic actinomycete isolated from marsh soil in Kuwait. | 2002 Mar |
|
Classification of three airborne bacteria and proposal of Hymenobacter aerophilus sp. nov. | 2002 Mar |
|
Paenibacillus chinjuensis sp. nov., a novel exopolysaccharide-producing bacterium. | 2002 Mar |
|
Major adenine products from 2-methyl-1,4-naphthoquinone-sensitized photoirradiation at 365 nm. | 2002 Mar 15 |
|
Molecular basis of proton motive force generation: structure of formate dehydrogenase-N. | 2002 Mar 8 |
|
Georgenia muralis gen. nov., sp. nov., a novel actinobacterium isolated from a medieval wall painting. | 2002 May |
|
Salinicoccus alkaliphilus sp. nov., a novel alkaliphile and moderate halophile from Baer Soda Lake in Inner Mongolia Autonomous Region, China. | 2002 May |
|
Lentibacillus salicampi gen. nov., sp. nov., a moderately halophilic bacterium isolated from a salt field in Korea. | 2002 Nov |
|
Shift of serum osteocalcin components between cord blood and blood at day 5 of life. | 2002 Nov |
|
Effects of redox cycling compounds on glutathione content and activity of glutathione-related enzymes in rainbow trout liver. | 2002 Nov |
|
Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. | 2002 Nov 1 |
|
Mechanisms for the formation of major oxidation products of adenine upon 365-nm irradiation with 2-methyl-1,4-naphthoquinone as a sensitizer. | 2002 Nov 29 |
|
Halococcus dombrowskii sp. nov., an archaeal isolate from a Permian alpine salt deposit. | 2002 Sep |
|
Pseudonocardia spinosispora sp. nov., isolated from Korean soil. | 2002 Sep |
|
Neocortical neurons cultured from mice with expanded CAG repeats in the huntingtin gene: unaltered vulnerability to excitotoxins and other insults. | 2003 |
|
Vitamin K(2) (menaquinone 4) reduces serum undercarboxylated osteocalcin level as early as 2 weeks in elderly women with established osteoporosis. | 2003 |
|
Serum markers variation consistent with autoschizis induced by ascorbic acid-menadione in patients with prostate cancer. | 2003 |
|
Microarray analysis of orthologous genes: conservation of the translational machinery across species at the sequence and expression level. | 2003 |
|
Complex II from phototrophic purple bacterium Rhodoferax fermentans displays rhodoquinol-fumarate reductase activity. | 2003 Apr |
|
Anthracyclines induce accumulation of iron in ferritin in myocardial and neoplastic cells: inhibition of the ferritin iron mobilization pathway. | 2003 Apr |
|
Synthesis and antifilarial evaluation of N1,Nn- xylofuranosylated diaminoalkanes. | 2003 Apr 17 |
|
A novel membrane-bound respiratory complex from Desulfovibrio desulfuricans ATCC 27774. | 2003 Aug 18 |
|
Paenibacillus kribbensis sp. nov. and Paenibacillus terrae sp. nov., bioflocculants for efficient harvesting of algal cells. | 2003 Jan |
|
Gemmatimonas aurantiaca gen. nov., sp. nov., a gram-negative, aerobic, polyphosphate-accumulating micro-organism, the first cultured representative of the new bacterial phylum Gemmatimonadetes phyl. nov. | 2003 Jul |
|
Rhodoglobus vestalii gen. nov., sp. nov., a novel psychrophilic organism isolated from an Antarctic Dry Valley lake. | 2003 Jul |
|
Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells. | 2003 Jun |
|
Jeotgalicoccus halotolerans gen. nov., sp. nov. and Jeotgalicoccus psychrophilus sp. nov., isolated from the traditional Korean fermented seafood jeotgal. | 2003 Mar |
|
Discriminating redox cycling and arylation pathways of reactive chemical toxicity in trout hepatocytes. | 2003 Mar |
|
Sequential inactivation of reactive oxygen species by combined overexpression of SOD isoforms and catalase in insulin-producing cells. | 2003 Mar 15 |
|
The menD and menE homologs code for 2-succinyl-6-hydroxyl-2,4-cyclohexadiene-1-carboxylate synthase and O-succinylbenzoic acid-CoA synthase in the phylloquinone biosynthetic pathway of Synechocystis sp. PCC 6803. | 2003 Mar 6 |
|
Halobacillus salinus sp. nov., isolated from a salt lake on the coast of the East Sea in Korea. | 2003 May |
|
Effects of menatetrenone on the bone and serum levels of vitamin K2 (menaquinone derivatives) in osteopenia induced by phenytoin in growing rats. | 2003 May |
|
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity. | 2003 May 2 |
|
Epidermal growth factor receptor is a common mediator of quinone-induced signaling leading to phosphorylation of connexin-43: role of glutathione and tyrosine phosphatases. | 2003 Oct 3 |
Sample Use Guides
Vitamin K deficiency:
Oral - 10 mg every six hours
Intravenous - 1-5 ug/kg/day
Severe hypoprothrombinaemia:
Oral - 10 mg three to four times a day
Intramuscular - 2.5-10 mg
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8837050
There was a significant decrease in electrical resistance in the brain endothelial cells, isolated from heterozygous transgenic mice relative to the brain endothelial cells, isolated from heterozygous non-transgenic mice from 1h after the administration of menadione at a concentration of 60 mg/ml.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:21:23 GMT 2023
by
admin
on
Fri Dec 15 15:21:23 GMT 2023
|
Record UNII |
723JX6CXY5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
598
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
||
|
LOINC |
3129-4
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
||
|
DSLD |
4178 (Number of products:1)
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
||
|
WHO-VATC |
QB02BA02
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
||
|
WHO-ATC |
B02BA02
Created by
admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
|
||
|
EPA PESTICIDE CODE |
6319
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4170
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
3354
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
CHEMBL590
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
DTXSID4021715
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
58-27-5
Created by
admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
|
PRIMARY | |||
|
SUB03142MIG
Created by
admin on Fri Dec 15 15:21:23 GMT 2023 , Edited by admin on Fri Dec 15 15:21:23 GMT 2023
|
PRIMARY | |||
|
m7169
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB00170
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
1381006
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
6728
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | RxNorm | ||
|
MENADIONE
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
4055
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
28869
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
D024483
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
200-372-6
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
C1505
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
CONCEPT | Dietary Supplement | ||
|
1683
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
723JX6CXY5
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
100000086399
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
C66086
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY | |||
|
723JX6CXY5
Created by
admin on Fri Dec 15 15:21:24 GMT 2023 , Edited by admin on Fri Dec 15 15:21:24 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> INHIBITOR |
IC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |